Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Renal Cell × Counseling × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 9 Neoplasms 4 Overweight 3 Obesity 3 Lung Neoplasms 3 Colorectal Neoplasms 3 Sleep Wake Disorders 2 Prostatic Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Lymphoma 2 Leukemia 2 Hematopoietic and Lymphoid System Neoplasm 2 Hematologic Neoplasms 2 Fatigue 2 Carcinoma, Non-Small-Cell Lung 2 Breast Carcinoma In Situ 2 Weight Loss 1 Uterine Cervical Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Obesity-Related Malignant Neoplasm 1 No Evidence of Disease 1 Neoplasm Metastasis 1 Motor Activity 1 Metastatic Pancreatic Adenocarcinoma 1 Leukemia, Myeloid, Acute 1 Intermittent Fasting 1 Hereditary Breast and Ovarian Cancer Syndrome 1 Hematopoietic and Lymphatic System Neoplasm 1 Head and Neck Carcinoma 1

Interventions

Nivolumab 63 pembrolizumab 62 cabozantinib 43 Ipilimumab 33 Magnetic Resonance Spectroscopy 30 Specimen Handling 26 lenvatinib 21 Axitinib 20 belzutifan 16 Sunitinib 16 Radiosurgery 13 Biopsy 13 atezolizumab 10 Everolimus 10 CTLA-4 Antigen 10 pazopanib 9 avelumab 8 Radiotherapy 8 Bevacizumab 8 fludarabine 6 cemiplimab 6 aldesleukin 6 Standard of Care 6 Nephrectomy 6 Immunoglobulin G 6 Cyclophosphamide 6 toripalimab 5 spartalizumab 5 Paclitaxel 5 tivozanib 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡